WO1998002240A1 - Preservation by foam formation - Google Patents
Preservation by foam formation Download PDFInfo
- Publication number
- WO1998002240A1 WO1998002240A1 PCT/US1997/012156 US9712156W WO9802240A1 WO 1998002240 A1 WO1998002240 A1 WO 1998002240A1 US 9712156 W US9712156 W US 9712156W WO 9802240 A1 WO9802240 A1 WO 9802240A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- foam
- drying
- biologically active
- vacuum
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
- Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Definitions
- the invention relates to methods for preserving sensitive biologically active solutes and suspensions, emulsions and dispersions of, for example, enzymes, proteins, viruses, serums, vaccines, liposomes and cell suspensions .
- the present invention is a method of preserving sensitive biological suspensions and solutions by forming stable foams from fluid materials to be dried, as an aid both to the drying of one or more biologically active substrates in the fluid and as an aid in preparing an easily soluble dried product suitable for further commercial use.
- the stable foams are formed by partially removing water in the biologically active sample to form a viscous liquid and by further subjecting the reduced liquid to vacuum to cause it to "boil" during further drying at temperatures substantially lower than 100 degrees C.
- the present invention is a method of preserving sensitive biological dispersions, suspensions, emulsions and solutions by forming stable foams from fluid materials to be dried, as an aid both to the drying of one or more biologically active substrates in the fluid and as an aid in preparing an easily divisible dried product suitable for further commercial use.
- the stable foams are formed by partially removing the water to form a viscous liquid and by further subjecting the reduced liquid to vacuum, to cause it to "boil" during further drying at temperatures substantially lower than 100 degrees C.
- reduced pressure is applied to viscous solutions or suspensions of biologically active materials to cause the solutions or suspensions to foam during boiling, and during the foaming process further solvent removal causes the ultimate production of a stable open-cell or closed-cell foam.
- foams are easily divisible by cutting, milling or other dividing techniques, and the foaming action itself enhances water removal by maximizing liquid surface area available for evaporation.
- the solvent fraction of the materials to be dried will be aqueous, however, it should be understood that the present method may be applied to solutions and suspensions of various types including those containing nonaqueous solvents or mixture of such solvents .
- the inventive apparatus is a novel combination of a vacuum pump with a temperature controlled desiccator device.
- Optional features of such a combination include sensors for temperature measurement and heat flow control, microprocessors for calculating other process parameters based on data collected from these and other sensors and etc.
- Such a device allows implementation of a novel two- dimensional vacuum and temperature protocol for drying.
- the foam forming process includes two steps: (a) an intensive dehydration of the solution or dispersion containing the biologically active agent by boiling under vacuum, to form a stable, non-collapsing foam and (b) subsequent secondary drying of the foams, to the extent that the foams are stable and do not collapse during storage.
- the invention provides a scalable method for preserving sensitive biologically active materials (proteins, enzymes, serums, vaccines, viruses, liposomes and cell suspensions) with a uniquely engineered drying method. Using this method, it is possible to rehydrate the samples with water or aqueous solutions to reverse the process to the initial biological activity. The method may be applied for the preservation of pharmaceutical, fluid or virtually any other biologically active products or solutes.
- foams are a kinetic process and depends on the rate of temperature and vacuum changes during formation of the foam as well as the initial concentration and composition of the solution or dispersion containing the biologically active substance. Stability of the foams may be further enhanced by the addition of surfactants or other synthetic or biological polymers as long as those additives do not interfere with the biological activity of the solute intended for conversion to dry form. Secondary drying and optional cooling of the formed and initially dry foams may be conducted to assure stability of the foam during storage. Cooling may be used to convert the foamed material to the glass state. Foams prepared according to the present invention may be stored whole or subdivided or milled, and when they are to be used need only be rehydrated in order to restore their original biologic activity.
- Aqueous 50% glycerol isocitrate dehydrogenase solution from Sigma Chemical Co. containing 59.4 units of activity per ml. was dialyzed for 5 hours in 0.1 M TRIS HC1 buffer (pH 7.4).
- the activity decrease was associated with decrease in the enzyme concentration because of dilution during the dialysis.
- the samples were rehydrated with 500 microliters water. Rehydration of the samples containing dry foams was an easy process that was completed within several seconds. Reconstituted sample was assayed for activity by assaying ability to reduce NADP, measured spectrophotometrically at 340 nm.
- the activity was 2.6 +/- 0.2 units/ml. which means there was no loss of activity during drying and subsequent storage at room temperature .
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
- Colloid Chemistry (AREA)
- Drying Of Solid Materials (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10506201A JP2000515856A (ja) | 1996-07-15 | 1997-07-14 | 泡沫形成による保存 |
| DE0914202T DE914202T1 (de) | 1996-07-15 | 1997-07-14 | Konservierung durch schaumformung |
| HU9903917A HUP9903917A3 (en) | 1996-07-15 | 1997-07-14 | Preservation by foam formation |
| NZ333738A NZ333738A (en) | 1996-07-15 | 1997-07-14 | Shelf preservation of biological active material by forming a mechanically stable foam thereof |
| EP97933415A EP0914202A4 (en) | 1996-07-15 | 1997-07-14 | PRESERVATION BY FORMATION OF FOAM |
| BR9711808-7A BR9711808A (pt) | 1996-07-15 | 1997-07-14 | Preservação através de formação de espuma. |
| EA199900268A EA001138B1 (ru) | 1996-07-15 | 1997-07-14 | Защита пенообразованием |
| IL12797197A IL127971A (en) | 1996-07-15 | 1997-07-14 | Preservation by creating foam |
| AU36606/97A AU714328B2 (en) | 1996-07-15 | 1997-07-14 | Preservation by foam formation |
| NO990158A NO990158D0 (no) | 1996-07-15 | 1999-01-14 | Konservering ved skumdannelse |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2179696P | 1996-07-15 | 1996-07-15 | |
| US60/021,796 | 1997-01-17 | ||
| US08/785,473 US5766520A (en) | 1996-07-15 | 1997-01-17 | Preservation by foam formation |
| US08/785,473 | 1997-01-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1998002240A1 true WO1998002240A1 (en) | 1998-01-22 |
| WO1998002240B1 WO1998002240B1 (en) | 1998-03-05 |
Family
ID=26695104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1997/012156 Ceased WO1998002240A1 (en) | 1996-07-15 | 1997-07-14 | Preservation by foam formation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5766520A (enExample) |
| EP (1) | EP0914202A4 (enExample) |
| JP (1) | JP2000515856A (enExample) |
| KR (1) | KR100457748B1 (enExample) |
| CN (1) | CN1116104C (enExample) |
| AU (1) | AU714328B2 (enExample) |
| BR (1) | BR9711808A (enExample) |
| CA (1) | CA2260233A1 (enExample) |
| CZ (1) | CZ7999A3 (enExample) |
| DE (1) | DE914202T1 (enExample) |
| EA (1) | EA001138B1 (enExample) |
| HU (1) | HUP9903917A3 (enExample) |
| IL (1) | IL127971A (enExample) |
| NO (1) | NO990158D0 (enExample) |
| NZ (1) | NZ333738A (enExample) |
| PL (1) | PL331174A1 (enExample) |
| TR (1) | TR199900127T2 (enExample) |
| WO (1) | WO1998002240A1 (enExample) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999027071A1 (en) * | 1997-11-26 | 1999-06-03 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| WO2000040696A1 (en) * | 1999-01-05 | 2000-07-13 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological materials at ambient temperatures by vitrification |
| WO2000066710A3 (en) * | 1999-05-04 | 2001-02-08 | Eric Edward Worrall | Method for the preservation of viruses and mycoplasma |
| WO2001037804A3 (en) * | 1999-11-22 | 2001-11-22 | Universal Preservation Technologies Inc | Preservation and formulation of bioactive materials |
| WO2002000201A3 (en) * | 2000-06-27 | 2002-04-18 | Hoffmann La Roche | Method for preparing a composition |
| US6537666B1 (en) | 2000-10-23 | 2003-03-25 | Universal Preservation Technologies, Inc. | Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals |
| US6692695B1 (en) | 1999-05-06 | 2004-02-17 | Quadrant Drug Delivery Limited | Industrial scale barrier technology for preservation of sensitive biological materials |
| US7153472B1 (en) | 2000-11-22 | 2006-12-26 | Quadrant Drug Delivery Limited | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers |
| EP1494651A4 (en) * | 2002-04-11 | 2010-10-13 | Medimmune Vaccines Inc | PRESERVATION OF BIO-ACTIVE MATERIALS WITH LYOPHILIZED FOAM |
Families Citing this family (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100291620B1 (ko) | 1992-09-29 | 2001-10-24 | 추후제출 | 부갑상선호르몬의활성단편의폐를통한전달방법 |
| ATE264096T1 (de) | 1994-03-07 | 2004-04-15 | Nektar Therapeutics | Verfahren und mittel zur verabreichung von insulin über die lunge |
| US20030113273A1 (en) * | 1996-06-17 | 2003-06-19 | Patton John S. | Methods and compositions for pulmonary delivery of insulin |
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| EP0782398A1 (en) | 1994-09-22 | 1997-07-09 | Quadrant Holdings Cambridge Limited | Compositions for use in rehydration and nutrition during athletic exercise and methods of making same |
| US6964771B1 (en) | 1995-06-07 | 2005-11-15 | Elan Drug Delivery Limited | Method for stably incorporating substances within dry, foamed glass matrices |
| US6509146B1 (en) | 1996-05-29 | 2003-01-21 | Universal Preservation Technologies, Inc. | Scalable long-term shelf preservation of sensitive biological solutions and suspensions |
| US6468782B1 (en) * | 1996-12-05 | 2002-10-22 | Quadrant Healthcare (Uk) Limited | Methods of preserving prokaryotic cells and compositions obtained thereby |
| GB9705588D0 (en) | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
| US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
| US20060116330A1 (en) * | 1997-07-08 | 2006-06-01 | The Iams Company | Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
| US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US6214054B1 (en) | 1998-09-21 | 2001-04-10 | Edwards Lifesciences Corporation | Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby |
| EP1144930A1 (en) | 1999-01-05 | 2001-10-17 | Universal Preservation Technologies, Inc. | Vacuum control system for foam drying apparatus |
| CA2382061A1 (en) * | 1999-08-19 | 2001-02-22 | Victor Bronshtein | Preservation of bacterial cells at ambient temperatures |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| CA2382133C (en) | 2000-05-10 | 2010-11-23 | Alliance Pharmaceutical Corporation | Phospholipid-based powders for drug delivery |
| WO2001094867A1 (en) | 2000-06-07 | 2001-12-13 | Universal Preservation Technologies, Inc. | Industrial scale barrier technology for preservation of sensitive biological materials |
| US6872357B1 (en) * | 2000-11-22 | 2005-03-29 | Quadrant Drug Delivery Limited | Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying |
| AU2002305461A1 (en) * | 2001-05-07 | 2002-11-18 | Universal Preservation Technologies, Inc. | Preservation of competent cells at ambient temperatures |
| US6884866B2 (en) * | 2001-10-19 | 2005-04-26 | Avant Immunotherapeutics, Inc. | Bulk drying and the effects of inducing bubble nucleation |
| WO2003053411A1 (en) | 2001-12-19 | 2003-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
| US6878168B2 (en) | 2002-01-03 | 2005-04-12 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
| HUE034801T2 (en) | 2002-11-01 | 2018-02-28 | Glaxosmithkline Biologicals Sa | Drying procedure |
| US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
| US20050100636A1 (en) * | 2003-11-10 | 2005-05-12 | Megan Botteri | [A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity] |
| US8877178B2 (en) * | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
| US20050158294A1 (en) * | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8894991B2 (en) * | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
| US20050152884A1 (en) * | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
| US9744227B2 (en) | 2004-06-02 | 2017-08-29 | Universal Stabilization Technologies, Inc. | Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof |
| EP2567708A3 (en) | 2004-06-02 | 2013-10-16 | Victor Bronshtein | Preservation by vaporization |
| JP2007277094A (ja) * | 2004-06-29 | 2007-10-25 | Chemo Sero Therapeut Res Inst | 改変ダニ主要アレルゲン含有医薬組成物 |
| EP1771503B1 (en) * | 2004-07-30 | 2014-09-03 | Enwave Corporation | Method for producing hydrocolloid foams |
| JP4938005B2 (ja) * | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティックであるラクトバシラス |
| BRPI0611492B1 (pt) * | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
| JP5214464B2 (ja) | 2005-12-28 | 2013-06-19 | アドバンスド バイオニュートリション コーポレーション | 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法 |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| US9453675B2 (en) * | 2006-02-10 | 2016-09-27 | Sp Industries, Inc. | Method of inducing nucleation of a material |
| CN101626682B (zh) | 2006-10-27 | 2014-04-16 | 爱德华兹生命科学公司 | 用于外科植入的生物组织 |
| WO2008076975A1 (en) | 2006-12-18 | 2008-06-26 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
| CA2673465A1 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal |
| EP2148923B1 (en) * | 2007-05-18 | 2012-08-22 | MedImmune, LLC | Preservation of bioactive materials by freeze dried foam |
| US9101691B2 (en) * | 2007-06-11 | 2015-08-11 | Edwards Lifesciences Corporation | Methods for pre-stressing and capping bioprosthetic tissue |
| AU2008280755B9 (en) | 2007-07-26 | 2014-09-25 | Sanofi Pasteur Limited | Antigen-adjuvant compositions and methods |
| EP2190974A4 (en) * | 2007-09-13 | 2016-01-20 | Enwave Corp | APPARATUS AND METHOD FOR DEHYDRATING BIOLOGICAL MATERIAL |
| US8357387B2 (en) * | 2007-12-21 | 2013-01-22 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| EP2329005A4 (en) * | 2008-09-12 | 2011-10-12 | Enwave Corp | DEVICE AND METHOD FOR DEHYDRATING BIOLOGICAL MATERIAL WITH FREEZERS AND MICROWAVES |
| CA2986751A1 (en) | 2009-03-27 | 2010-09-30 | Intervet International B.V. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| AU2010254235B2 (en) | 2009-05-26 | 2015-04-02 | Advanced Bionutrition Corporation | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| EP2475393A4 (en) * | 2009-09-14 | 2013-08-21 | Vu Truong-Le | FORMULATION FOR THE ROOM TEMPERATURE STABILIZATION OF A WEAKED LIVING BACTERIAL VACCINE |
| CA2785815C (en) | 2010-01-28 | 2018-04-24 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| EP2674174B1 (en) | 2010-03-23 | 2019-10-16 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
| EP2582411B1 (en) | 2010-06-17 | 2019-05-01 | Edwards Lifesciences Corporation | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates |
| US8906601B2 (en) | 2010-06-17 | 2014-12-09 | Edwardss Lifesciences Corporation | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates |
| ES2676656T3 (es) | 2010-08-13 | 2018-07-23 | Advanced Bionutrition Corp. | Composición estabilizante de almacenamiento en seco para materiales biológicos |
| US9351829B2 (en) | 2010-11-17 | 2016-05-31 | Edwards Lifesciences Corporation | Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability |
| US10238771B2 (en) | 2012-11-08 | 2019-03-26 | Edwards Lifesciences Corporation | Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system |
| CA2913971C (en) | 2013-05-31 | 2022-08-02 | Universal Stabilization Technologies, Inc. | Polymeric compositions containing ambient-temperature stable biopharmaceuticals & methods for formulation thereof |
| US9615922B2 (en) | 2013-09-30 | 2017-04-11 | Edwards Lifesciences Corporation | Method and apparatus for preparing a contoured biological tissue |
| US10959839B2 (en) | 2013-10-08 | 2021-03-30 | Edwards Lifesciences Corporation | Method for directing cellular migration patterns on a biological tissue |
| US9938558B2 (en) | 2015-06-25 | 2018-04-10 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| US10851399B2 (en) | 2015-06-25 | 2020-12-01 | Native Microbials, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| MX388995B (es) | 2015-06-25 | 2025-03-20 | Native Microbials Inc | Métodos, aparatos y sistemas para analizar cepas de microorganismos de comunidades heterogéneas complejas, predecir e indentificar sus relaciones funcionales e interacciones y seleccionar y sintetizar conjuntos microbianos basados en estos. |
| KR102685914B1 (ko) | 2015-07-29 | 2024-07-16 | 어드밴스드 바이오뉴트리션 코프. | 특수 식이 용도를 위한 안정한 프로바이오틱 건조 조성물 |
| CN109874294B (zh) | 2016-04-15 | 2023-06-20 | 原生微生物股份有限公司 | 通过施用微生物聚生体或其纯化菌株来提高禽类的农业生产的方法 |
| CN106434840B (zh) * | 2016-12-02 | 2019-08-09 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法 |
| CN110352250A (zh) | 2016-12-28 | 2019-10-18 | 埃斯库斯生物科技股份公司 | 用于通过示踪剂分析法对复杂异质群落进行微生物株系分析、确定其功能关系及相互作用以及合成包括给药微生物群集和接种微生物群集的微生物群集的方法、设备和系统 |
| AU2017386658A1 (en) | 2016-12-28 | 2019-07-25 | Native Microbials, Inc. | Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon |
| CN106701887B (zh) * | 2017-01-03 | 2020-01-17 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法 |
| CN106676160B (zh) * | 2017-01-03 | 2020-02-21 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法 |
| CN106591415B (zh) * | 2017-01-03 | 2019-12-10 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法 |
| CN106676161B (zh) * | 2017-01-03 | 2020-01-21 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法 |
| US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
| EP3615006A4 (en) * | 2017-04-28 | 2020-12-30 | Universal Stabilization Technologies, Inc. | THERMOSTABLE ANTIGENIC POLIOMYELITIC VACCINES AND RELATED PROCESSES |
| CN110678590B (zh) | 2017-05-31 | 2022-07-19 | 爱德华兹生命科学公司 | 胶原纤维和由其形成的制品 |
| UY37939A (es) | 2017-10-18 | 2019-04-30 | Ascus Biosciences Inc | Aumento de la producción de aves de corral mediante la administración de un bioensamblaje sintético de microbios o cepas purificadas de los mismos |
| CA3081049A1 (en) | 2018-01-23 | 2019-08-01 | Edwards Lifesciences Corporation | Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby |
| JP7138336B2 (ja) * | 2018-06-29 | 2022-09-16 | 国立大学法人九州工業大学 | 生体由来の水溶性高分子乾燥品の製造方法及びその製造装置 |
| WO2020092205A1 (en) | 2018-11-01 | 2020-05-07 | Edwards Lifesciences Corporation | Transcatheter pulmonic regenerative valve |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5271881A (en) * | 1987-09-28 | 1993-12-21 | Redding Bruce K | Apparatus and method for making microcapsules |
| US5409703A (en) * | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
| US5565318A (en) * | 1994-09-02 | 1996-10-15 | Pharmacia Biotech, Inc. | Room temperature stable reagent semi-spheres |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4642903A (en) * | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
| DE229810T1 (de) * | 1985-07-09 | 1987-11-05 | Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire | Beschuetzung von proteinen und aehnlichem. |
| GB8903593D0 (en) * | 1989-02-16 | 1989-04-05 | Pafra Ltd | Storage of materials |
| US5200399A (en) * | 1990-09-14 | 1993-04-06 | Boyce Thompson Institute For Plant Research, Inc. | Method of protecting biological materials from destructive reactions in the dry state |
| AU659645B2 (en) * | 1991-06-26 | 1995-05-25 | Inhale Therapeutic Systems | Storage of materials |
| CZ391297A3 (cs) * | 1995-06-07 | 1998-05-13 | Quadrant Holdings Cambridge Limited | Způsob přípravy tenké porovité skelné matrice a prostředek tím získaný |
-
1997
- 1997-01-17 US US08/785,473 patent/US5766520A/en not_active Expired - Fee Related
- 1997-07-14 EA EA199900268A patent/EA001138B1/ru not_active IP Right Cessation
- 1997-07-14 DE DE0914202T patent/DE914202T1/de active Pending
- 1997-07-14 CA CA002260233A patent/CA2260233A1/en not_active Abandoned
- 1997-07-14 BR BR9711808-7A patent/BR9711808A/pt unknown
- 1997-07-14 CZ CZ9979A patent/CZ7999A3/cs unknown
- 1997-07-14 AU AU36606/97A patent/AU714328B2/en not_active Ceased
- 1997-07-14 EP EP97933415A patent/EP0914202A4/en not_active Withdrawn
- 1997-07-14 HU HU9903917A patent/HUP9903917A3/hu not_active Application Discontinuation
- 1997-07-14 CN CN97196422A patent/CN1116104C/zh not_active Expired - Fee Related
- 1997-07-14 PL PL97331174A patent/PL331174A1/xx unknown
- 1997-07-14 NZ NZ333738A patent/NZ333738A/xx unknown
- 1997-07-14 JP JP10506201A patent/JP2000515856A/ja not_active Ceased
- 1997-07-14 WO PCT/US1997/012156 patent/WO1998002240A1/en not_active Ceased
- 1997-07-14 IL IL12797197A patent/IL127971A/en not_active IP Right Cessation
- 1997-07-14 KR KR10-1999-7000253A patent/KR100457748B1/ko not_active Expired - Fee Related
- 1997-07-14 TR TR1999/00127T patent/TR199900127T2/xx unknown
-
1999
- 1999-01-14 NO NO990158A patent/NO990158D0/no not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5271881A (en) * | 1987-09-28 | 1993-12-21 | Redding Bruce K | Apparatus and method for making microcapsules |
| US5409703A (en) * | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
| US5565318A (en) * | 1994-09-02 | 1996-10-15 | Pharmacia Biotech, Inc. | Room temperature stable reagent semi-spheres |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999027071A1 (en) * | 1997-11-26 | 1999-06-03 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| US6306345B1 (en) | 1998-05-06 | 2001-10-23 | Universal Preservation Technologies, Inc. | Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures |
| WO2000040696A1 (en) * | 1999-01-05 | 2000-07-13 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological materials at ambient temperatures by vitrification |
| WO2000066710A3 (en) * | 1999-05-04 | 2001-02-08 | Eric Edward Worrall | Method for the preservation of viruses and mycoplasma |
| US6692695B1 (en) | 1999-05-06 | 2004-02-17 | Quadrant Drug Delivery Limited | Industrial scale barrier technology for preservation of sensitive biological materials |
| WO2001037804A3 (en) * | 1999-11-22 | 2001-11-22 | Universal Preservation Technologies Inc | Preservation and formulation of bioactive materials |
| US6534087B2 (en) | 2000-06-27 | 2003-03-18 | Hoffmann-La Roche Inc. | Process for preparing a pharmaceutical composition |
| WO2002000201A3 (en) * | 2000-06-27 | 2002-04-18 | Hoffmann La Roche | Method for preparing a composition |
| US7074431B2 (en) * | 2000-06-27 | 2006-07-11 | Hoffmann-La Roche Inc. | Process for preparing a pharmaceutical composition |
| HRP20021009B1 (hr) * | 2000-06-27 | 2011-07-31 | F. Hoffmann - La Roche Ag | Postupak za pripremu pripravka |
| US6537666B1 (en) | 2000-10-23 | 2003-03-25 | Universal Preservation Technologies, Inc. | Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals |
| US7153472B1 (en) | 2000-11-22 | 2006-12-26 | Quadrant Drug Delivery Limited | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers |
| EP1494651A4 (en) * | 2002-04-11 | 2010-10-13 | Medimmune Vaccines Inc | PRESERVATION OF BIO-ACTIVE MATERIALS WITH LYOPHILIZED FOAM |
| US8067017B2 (en) | 2002-04-11 | 2011-11-29 | Medimmune, Llc | Preservation of bioactive materials by freeze dried foam |
| US8343518B2 (en) | 2002-04-11 | 2013-01-01 | Medimmune, Llc | Preservation of bioactive materials by freeze dried foam |
| EP2591771A1 (en) * | 2002-04-11 | 2013-05-15 | MedImmune, LLC | Preservation of bioactive materials by freeze dried foam |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0914202A4 (en) | 2004-09-01 |
| CA2260233A1 (en) | 1998-01-22 |
| CN1226842A (zh) | 1999-08-25 |
| EA199900268A1 (ru) | 1999-10-28 |
| HUP9903917A3 (en) | 2000-06-28 |
| US5766520A (en) | 1998-06-16 |
| AU714328B2 (en) | 1999-12-23 |
| EP0914202A1 (en) | 1999-05-12 |
| TR199900127T2 (xx) | 1999-04-21 |
| NO990158L (no) | 1999-01-14 |
| KR20000023779A (ko) | 2000-04-25 |
| BR9711808A (pt) | 2000-01-18 |
| NO990158D0 (no) | 1999-01-14 |
| EA001138B1 (ru) | 2000-10-30 |
| CN1116104C (zh) | 2003-07-30 |
| CZ7999A3 (cs) | 1999-11-17 |
| IL127971A (en) | 2001-09-13 |
| AU3660697A (en) | 1998-02-09 |
| PL331174A1 (en) | 1999-06-21 |
| HUP9903917A2 (hu) | 2000-03-28 |
| KR100457748B1 (ko) | 2004-11-17 |
| JP2000515856A (ja) | 2000-11-28 |
| NZ333738A (en) | 2000-09-29 |
| IL127971A0 (en) | 1999-11-30 |
| DE914202T1 (de) | 2000-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5766520A (en) | Preservation by foam formation | |
| US6509146B1 (en) | Scalable long-term shelf preservation of sensitive biological solutions and suspensions | |
| EP1032647B1 (en) | Preservation of sensitive biological samples by vitrification | |
| WO1998002240B1 (en) | Preservation by foam formation | |
| EP1750760B1 (en) | Preservation by vaporization | |
| Hahn-Hägerdal | Water activity: a possible external regulator in biotechnical processes | |
| US5240843A (en) | Enzyme stabilisation | |
| US6872357B1 (en) | Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying | |
| US20030022333A1 (en) | Long-term shelf preservation by vitrification | |
| BRPI0112638B1 (pt) | Meio de preservação e estocagem para materiais biológicos | |
| AU2001268057A1 (en) | Preservation and storage medium for biological materials | |
| JPH02265984A (ja) | 物質の貯蔵 | |
| CA2391379A1 (en) | Preservation of sensitive biological material | |
| CN115024310B (zh) | 一种细胞冻干保存剂及其制备方法 | |
| CN1286725A (zh) | 敏感性生物样品的玻化保质法 | |
| MXPA00005123A (en) | Preservation of sensitive biological samples by vitrification | |
| Salemink | Cell and cell constituent freeze-drying: fundamentals and principles | |
| Rapoporta et al. | Anhydrobiosis in Yeast: Stabilization by Exogenous Lactose1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 97196422.X Country of ref document: CN |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| ENP | Entry into the national phase |
Ref document number: 2260233 Country of ref document: CA Ref document number: 2260233 Country of ref document: CA Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PV1999-79 Country of ref document: CZ |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 333738 Country of ref document: NZ |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PA/A/1999/000592 Country of ref document: MX |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1019997000253 Country of ref document: KR Ref document number: 1999/00127 Country of ref document: TR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1997933415 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 199900268 Country of ref document: EA |
|
| WWP | Wipo information: published in national office |
Ref document number: 1997933415 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: PV1999-79 Country of ref document: CZ |
|
| WWP | Wipo information: published in national office |
Ref document number: 1019997000253 Country of ref document: KR |
|
| WWR | Wipo information: refused in national office |
Ref document number: PV1999-79 Country of ref document: CZ |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1019997000253 Country of ref document: KR |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1997933415 Country of ref document: EP |